Insiders Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:30:47 2024-11-29 am EST			5-day change	1st Jan Change
93.27 ^CHF	-0.12%		-0.44%	+9.90%

Nov. 27	Swiss Market Index Recovers; Nestlé Shares Edge Up	MT
Nov. 27	Global markets live: HP, Dell, Amazon, EasyJet, HSBC...

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Maeve Waldron-Lynch to Join Tango Therapeutics, Inc. as Senior Vice President, Head of Clinical Development	Nov. 06	CI
NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	Oct. 30	CI
NovoCure Limited Announces CFO Appointment	Oct. 30	CI
Incannex Healthcare Inc. Announces Appointment of Dr. Lou Barbato as Chief Medical Officer	Oct. 24	CI
Kyverna Therapeutics, Inc. Announces CEO Changes	Sep. 16	CI
EXECUTIVE CHANGES: Invinity replaces CEO; Gulf Keystone chair dies	Sep. 06	AN
EDX Medical Group Names New Chief Commercial Officer	Sep. 05	MT
Bayer: new CEO for Bayer HealthCare in France	Aug. 29	CF
Sana Biotechnology, Inc. Announces the Appointment of Dhaval Patel as Executive Vice President and Chief Scientific Officer	Aug. 26	CI
Page Industries Limited Announces Change in Directorate	Aug. 08	CI
EXECUTIVE CHANGES: NWF and Northern Bear pick new board chairs	Jul. 22	AN
Novartis AG Announces That Charles L. Sawyers and William T. Winters Will Not Stand for Re-Election	Jul. 18	CI
Novartis raises 2024 profit guidance for second time	Jul. 18	RE
Lexicon Pharmaceuticals Names Mike Exton CEO, Jeff Wade Operating Chief	Jul. 08	MT
Nkarta, Inc. Appoints George Vratsanos as Board of Directors	Jun. 13	CI
Chimeric Therapeutics Appoints COO; Shares Rise 4%	May. 01	MT
Avacta picks Christina Coughlin to replace long-serving CEO	May. 01	AN
Vas Narasimhan, CEO of Novartis: 40% margin by 2027	Apr. 23	MT
Novartis Nominates Former Bristol Myers Squibb CEO as New Chair	Apr. 23	MT
Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand	Apr. 23	MT
Novartis Raises Guidance on Profit, Sales Growth	Apr. 23	DJ
BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket	Mar. 20	MT
BioNTech Names New Chief Commercial Officer	Mar. 20	MT
Abivax appoints new head of quality	Feb. 07	CF
Mondelez: Haleon CEO joins the Board of Directors	Feb. 02	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

NOVARTIS : Q3 beat and a guidance upgrade; today’s dip is a buying opportunity

October 29, 2024 at 02:16 pm EDT

Vas Narasimhan, CEO of Novartis: 40% margin by 2027

April 23, 2024 at 07:18 am EDT

Novartis AG : Sandoz takes its first steps on the stock exchange

October 04, 2023 at 10:32 am EDT